Commitment to
Good Governance
Our commitment to excellence is linked to observing and complying with the law and regulations applicable to us as a listed pharmaceutical company. At ROVI, we have furnished ourselves with policies and procedures that reflect our ethics in our work and in our relations with our stakeholders. Here, you will find information that will give you a greater insight into how we work.
Our commitment to the SDGs
Key indicators
42,85% Independent
directors
42,85% Female
directors
Approval of
ESG Master Plan 2023-2025
by Board of Directors
Compensation of
Board members linked to attainment of ESG objectives
Member of the United Nations Global Compact
As a member of the United Nations Global Compact, ROVI supports, by adopting and transmitting them, the incorporation of the principles of said Compact, as well as other international instruments, such as the Core Conventions of the International Labour Organisation (ILO) related to respect for freedom of association and the right to collective bargaining.
Codes, policies and plans
At corporate level, we manage ESG aspects through internal codes of conduct and corporate policies, which establish common principles and serve as a guide for the Company’s performance in the social, environmental and governance areas.
Our performance
Board of Directors
Governance body responsible for the oversight and control of the company. Likewise, it is responsible for the Financial and Non-financial Risk Control Policy and for the periodic monitoring of the internal information and control systems.
Risks
We consider that risk control and management contribute to achieving greater efficiency and efficacy in the company's operations and attaining the corporate goals.
Compliance
We strive to carry out our activities while complying with the principles of business ethics.
Commitment to transparency
Society requires the pharmaceutical industry to provide it with the best medicines possible. To reach this goal, it is necessary to invest in both Research and Development and training, with the need for close collaboration with healthcare professionals and organisations and patients’ organisations. This valuable exchange of knowledge and experience allows the most innovative treatments to be provided, thus giving the patients hope and enhancing their quality of life.